APO Research
Talk to an analyst

APO RESEARCH · REPORT

Famciclovir

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Famciclovir Market Outlook and Growth Opportunities 2026

20 December 2025197 pages

Choose your research edition.

Industry ResearchFamciclovir Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Famciclovir Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Famciclovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Famciclovir Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Famciclovir Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Famciclovir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Famciclovir market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Famciclovir market include Teva, Shandong Luoxin Pharmaceutical Group, Novartis, Mylan, Hainan choitec Pharmaceuticals, Chengdu Diao Pharmaceutical Group, Beijing Jialin Pharmaceutical, Macleods Pharmaceuticals and HISUN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Famciclovir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Famciclovir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Famciclovir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Famciclovir market size, projected growth trends, production technologies, key applications, and end-use industries.

Famciclovir Segment by Company

Teva

Shandong Luoxin Pharmaceutical Group

Novartis

Mylan

Hainan choitec Pharmaceuticals

Chengdu Diao Pharmaceutical Group

Beijing Jialin Pharmaceutical

Macleods Pharmaceuticals

HISUN

Hikma

HETERO

Cipla

Aurobindo Pharma

Apotex

Famciclovir Segment by Type

125 mg Tablets

250 mg Tablets

500 mg Tablets

Famciclovir Segment by Application

Cold Sores

Shingles

Genital Herpes

Famciclovir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Famciclovir status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Famciclovir market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Famciclovir significant trends, drivers, influence factors in global and regions.

6. To analyze Famciclovir competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Famciclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Famciclovir market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Famciclovir industry.

Chapter 3: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Famciclovir in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Famciclovir Industry Trends Table 2. Famciclovir Industry Drivers Table 3. Famciclovir Industry Opportunities and Challenges Table 4. Famciclovir Industry Restraints Table 5. Global Famciclovir Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Famciclovir Revenue Share by Company (2021-2026) Table 7. Global Famciclovir Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Famciclovir Sales Volume Share by Company (2021-2026) Table 9. Global Famciclovir Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Famciclovir Company Ranking, (2024-2026) & (USD Million) Table 11. Global Famciclovir Key Company Manufacturing Base & Headquarters Table 12. Global Famciclovir Company, Product Type & Application Table 13. Global Famciclovir Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Famciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 125 mg Tablets Table 18. Significant Companies of 250 mg Tablets Table 19. Significant Companies of 500 mg Tablets Table 20. Global Famciclovir Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Famciclovir Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Famciclovir Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Famciclovir Sales Volume Share by Type (2021-2026) Table 24. Global Famciclovir Sales Volume Share by Type (2027-2032) Table 25. Global Famciclovir Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Famciclovir Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Famciclovir Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Famciclovir Sales Value Share by Type (2021-2026) Table 29. Global Famciclovir Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cold Sores Table 31. Significant Companies of Shingles Table 32. Significant Companies of Genital Herpes Table 33. Global Famciclovir Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Famciclovir Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Famciclovir Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Famciclovir Sales Volume Share by Application (2021-2026) Table 37. Global Famciclovir Sales Volume Share by Application (2027-2032) Table 38. Global Famciclovir Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Famciclovir Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Famciclovir Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Famciclovir Sales Value Share by Application (2021-2026) Table 42. Global Famciclovir Sales Value Share by Application (2027-2032) Table 43. Global Famciclovir Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Famciclovir Sales by Region (2021-2026) & (W Units) Table 45. Global Famciclovir Sales Market Share by Region (2021-2026) Table 46. Global Famciclovir Sales by Region (2027-2032) & (W Units) Table 47. Global Famciclovir Sales Market Share by Region (2027-2032) Table 48. Global Famciclovir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Famciclovir Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Famciclovir Sales Value Share by Region (2021-2026) Table 51. Global Famciclovir Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Famciclovir Sales Value Share by Region (2027-2032) Table 53. Global Famciclovir Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Famciclovir Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Famciclovir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Famciclovir Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Famciclovir Sales by Country (2021-2026) & (W Units) Table 58. Global Famciclovir Sales Market Share by Country (2021-2026) Table 59. Global Famciclovir Sales by Country (2027-2032) & (W Units) Table 60. Global Famciclovir Sales Market Share by Country (2027-2032) Table 61. Global Famciclovir Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Famciclovir Sales Value Market Share by Country (2021-2026) Table 63. Global Famciclovir Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Famciclovir Sales Value Market Share by Country (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Teva Famciclovir Product Portfolio Table 69. Teva Recent Development Table 70. Shandong Luoxin Pharmaceutical Group Company Information Table 71. Shandong Luoxin Pharmaceutical Group Business Overview Table 72. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio Table 74. Shandong Luoxin Pharmaceutical Group Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis Famciclovir Product Portfolio Table 79. Novartis Recent Development Table 80. Mylan Company Information Table 81. Mylan Business Overview Table 82. Mylan Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Mylan Famciclovir Product Portfolio Table 84. Mylan Recent Development Table 85. Hainan choitec Pharmaceuticals Company Information Table 86. Hainan choitec Pharmaceuticals Business Overview Table 87. Hainan choitec Pharmaceuticals Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Hainan choitec Pharmaceuticals Famciclovir Product Portfolio Table 89. Hainan choitec Pharmaceuticals Recent Development Table 90. Chengdu Diao Pharmaceutical Group Company Information Table 91. Chengdu Diao Pharmaceutical Group Business Overview Table 92. Chengdu Diao Pharmaceutical Group Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio Table 94. Chengdu Diao Pharmaceutical Group Recent Development Table 95. Beijing Jialin Pharmaceutical Company Information Table 96. Beijing Jialin Pharmaceutical Business Overview Table 97. Beijing Jialin Pharmaceutical Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Beijing Jialin Pharmaceutical Famciclovir Product Portfolio Table 99. Beijing Jialin Pharmaceutical Recent Development Table 100. Macleods Pharmaceuticals Company Information Table 101. Macleods Pharmaceuticals Business Overview Table 102. Macleods Pharmaceuticals Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Macleods Pharmaceuticals Famciclovir Product Portfolio Table 104. Macleods Pharmaceuticals Recent Development Table 105. HISUN Company Information Table 106. HISUN Business Overview Table 107. HISUN Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. HISUN Famciclovir Product Portfolio Table 109. HISUN Recent Development Table 110. Hikma Company Information Table 111. Hikma Business Overview Table 112. Hikma Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Hikma Famciclovir Product Portfolio Table 114. Hikma Recent Development Table 115. HETERO Company Information Table 116. HETERO Business Overview Table 117. HETERO Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. HETERO Famciclovir Product Portfolio Table 119. HETERO Recent Development Table 120. Cipla Company Information Table 121. Cipla Business Overview Table 122. Cipla Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Cipla Famciclovir Product Portfolio Table 124. Cipla Recent Development Table 125. Aurobindo Pharma Company Information Table 126. Aurobindo Pharma Business Overview Table 127. Aurobindo Pharma Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Aurobindo Pharma Famciclovir Product Portfolio Table 129. Aurobindo Pharma Recent Development Table 130. Apotex Company Information Table 131. Apotex Business Overview Table 132. Apotex Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Apotex Famciclovir Product Portfolio Table 134. Apotex Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Famciclovir Distributors List Table 138. Famciclovir Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Famciclovir Product Image Figure 2. Global Famciclovir Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Famciclovir Sales Value (2021-2032) & (US$ Million) Figure 4. Global Famciclovir Sales (2021-2032) & (W Units) Figure 5. Global Famciclovir Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Famciclovir Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 125 mg Tablets Image Figure 10. 250 mg Tablets Image Figure 11. 500 mg Tablets Image Figure 12. Global Famciclovir Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Famciclovir Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Famciclovir Sales Volume Share by Type (2021-2032) Figure 15. Global Famciclovir Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Famciclovir Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Famciclovir Sales Value Share by Type (2021-2032) Figure 18. Cold Sores Image Figure 19. Shingles Image Figure 20. Genital Herpes Image Figure 21. Global Famciclovir Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Famciclovir Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Famciclovir Sales Volume Share by Application (2021-2032) Figure 24. Global Famciclovir Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Famciclovir Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Famciclovir Sales Value Share by Application (2021-2032) Figure 27. Global Famciclovir Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Famciclovir Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Famciclovir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Famciclovir Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Famciclovir Sales Value (2021-2032) & (US$ Million) Figure 32. North America Famciclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Famciclovir Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Famciclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Famciclovir Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Famciclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Famciclovir Sales Value (2021-2032) & (US$ Million) Figure 38. South America Famciclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Famciclovir Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Famciclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Famciclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Famciclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Famciclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Famciclovir Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Famciclovir Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 125 mg Tablets
  • 250 mg Tablets
  • 500 mg Tablets
Applications
  • Cold Sores
  • Shingles
  • Genital Herpes
Companies covered
  • Teva
  • Shandong Luoxin Pharmaceutical Group
  • Novartis
  • Mylan
  • Hainan choitec Pharmaceuticals
  • Chengdu Diao Pharmaceutical Group
  • Beijing Jialin Pharmaceutical
  • Macleods Pharmaceuticals
  • HISUN
  • Hikma
  • HETERO
  • Cipla
  • Aurobindo Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Famciclovir Sales Value (2021-2032)
  4. 1.2.2 Global Famciclovir Sales Volume (2021-2032)
  5. 1.2.3 Global Famciclovir Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Famciclovir Market Dynamics
  1. 2.1 Famciclovir Industry Trends
  2. 2.2 Famciclovir Industry Drivers
  3. 2.3 Famciclovir Industry Opportunities and Challenges
  4. 2.4 Famciclovir Industry Restraints
3 Famciclovir Market by Company
  1. 3.1 Global Famciclovir Company Revenue Ranking in 2025
  2. 3.2 Global Famciclovir Revenue by Company (2021-2026)
  3. 3.3 Global Famciclovir Sales Volume by Company (2021-2026)
  4. 3.4 Global Famciclovir Average Price by Company (2021-2026)
  5. 3.5 Global Famciclovir Company Ranking (2024-2026)
  6. 3.6 Global Famciclovir Company Manufacturing Base and Headquarters
  7. 3.7 Global Famciclovir Company Product Type and Application
  8. 3.8 Global Famciclovir Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Famciclovir Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Famciclovir Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Famciclovir Market by Type
  1. 4.1 Famciclovir Type Introduction
  2. 4.1.1 125 mg Tablets
  3. 4.1.2 250 mg Tablets
  4. 4.1.3 500 mg Tablets
  5. 4.2 Global Famciclovir Sales Volume by Type
  6. 4.2.1 Global Famciclovir Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Famciclovir Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Famciclovir Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Famciclovir Sales Value by Type
  10. 4.3.1 Global Famciclovir Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Famciclovir Sales Value by Type (2021-2032)
  12. 4.3.3 Global Famciclovir Sales Value Share by Type (2021-2032)
5 Famciclovir Market by Application
  1. 5.1 Famciclovir Application Introduction
  2. 5.1.1 Cold Sores
  3. 5.1.2 Shingles
  4. 5.1.3 Genital Herpes
  5. 5.2 Global Famciclovir Sales Volume by Application
  6. 5.2.1 Global Famciclovir Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Famciclovir Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Famciclovir Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Famciclovir Sales Value by Application
  10. 5.3.1 Global Famciclovir Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Famciclovir Sales Value by Application (2021-2032)
  12. 5.3.3 Global Famciclovir Sales Value Share by Application (2021-2032)
6 Famciclovir Regional Sales and Value Analysis
  1. 6.1 Global Famciclovir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Famciclovir Sales by Region (2021-2032)
  3. 6.2.1 Global Famciclovir Sales by Region: 2021-2026
  4. 6.2.2 Global Famciclovir Sales by Region (2027-2032)
  5. 6.3 Global Famciclovir Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Famciclovir Sales Value by Region (2021-2032)
  7. 6.4.1 Global Famciclovir Sales Value by Region: 2021-2026
  8. 6.4.2 Global Famciclovir Sales Value by Region (2027-2032)
  9. 6.5 Global Famciclovir Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Famciclovir Sales Value (2021-2032)
  12. 6.6.2 North America Famciclovir Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Famciclovir Sales Value (2021-2032)
  15. 6.7.2 Europe Famciclovir Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Famciclovir Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Famciclovir Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Famciclovir Sales Value (2021-2032)
  21. 6.9.2 South America Famciclovir Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Famciclovir Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Famciclovir Sales Value Share by Country, 2025 VS 2032
7 Famciclovir Country-level Sales and Value Analysis
  1. 7.1 Global Famciclovir Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Famciclovir Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Famciclovir Sales by Country (2021-2032)
  4. 7.3.1 Global Famciclovir Sales by Country (2021-2026)
  5. 7.3.2 Global Famciclovir Sales by Country (2027-2032)
  6. 7.4 Global Famciclovir Sales Value by Country (2021-2032)
  7. 7.4.1 Global Famciclovir Sales Value by Country (2021-2026)
  8. 7.4.2 Global Famciclovir Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Famciclovir Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Famciclovir Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Famciclovir Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Famciclovir Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Famciclovir Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Famciclovir Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Famciclovir Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Famciclovir Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Famciclovir Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Famciclovir Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Famciclovir Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Famciclovir Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Famciclovir Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Famciclovir Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Famciclovir Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Famciclovir Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Famciclovir Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Famciclovir Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Famciclovir Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Famciclovir Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Famciclovir Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Famciclovir Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Famciclovir Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Famciclovir Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Famciclovir Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Famciclovir Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Famciclovir Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Famciclovir Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Famciclovir Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Famciclovir Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Famciclovir Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Famciclovir Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Famciclovir Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Famciclovir Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Famciclovir Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Famciclovir Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Famciclovir Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Famciclovir Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Famciclovir Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Famciclovir Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Famciclovir Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Famciclovir Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Famciclovir Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Famciclovir Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Famciclovir Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Famciclovir Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Famciclovir Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Famciclovir Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Famciclovir Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Famciclovir Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Famciclovir Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Famciclovir Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Famciclovir Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Famciclovir Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Famciclovir Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Famciclovir Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Famciclovir Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Famciclovir Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Famciclovir Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Famciclovir Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Famciclovir Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Famciclovir Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Famciclovir Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Famciclovir Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Famciclovir Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Famciclovir Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Famciclovir Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Famciclovir Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Famciclovir Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Famciclovir Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Famciclovir Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Famciclovir Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Famciclovir Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Famciclovir Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Famciclovir Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Famciclovir Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Famciclovir Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Famciclovir Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Famciclovir Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Famciclovir Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Famciclovir Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Famciclovir Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Famciclovir Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Famciclovir Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Famciclovir Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Famciclovir Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Shandong Luoxin Pharmaceutical Group
  8. 8.2.1 Shandong Luoxin Pharmaceutical Group Company Information
  9. 8.2.2 Shandong Luoxin Pharmaceutical Group Business Overview
  10. 8.2.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
  12. 8.2.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Famciclovir Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Famciclovir Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Famciclovir Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Famciclovir Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Hainan choitec Pharmaceuticals
  26. 8.5.1 Hainan choitec Pharmaceuticals Company Information
  27. 8.5.2 Hainan choitec Pharmaceuticals Business Overview
  28. 8.5.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
  30. 8.5.5 Hainan choitec Pharmaceuticals Recent Developments
  31. 8.6 Chengdu Diao Pharmaceutical Group
  32. 8.6.1 Chengdu Diao Pharmaceutical Group Company Information
  33. 8.6.2 Chengdu Diao Pharmaceutical Group Business Overview
  34. 8.6.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
  36. 8.6.5 Chengdu Diao Pharmaceutical Group Recent Developments
  37. 8.7 Beijing Jialin Pharmaceutical
  38. 8.7.1 Beijing Jialin Pharmaceutical Company Information
  39. 8.7.2 Beijing Jialin Pharmaceutical Business Overview
  40. 8.7.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
  42. 8.7.5 Beijing Jialin Pharmaceutical Recent Developments
  43. 8.8 Macleods Pharmaceuticals
  44. 8.8.1 Macleods Pharmaceuticals Company Information
  45. 8.8.2 Macleods Pharmaceuticals Business Overview
  46. 8.8.3 Macleods Pharmaceuticals Famciclovir Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio
  48. 8.8.5 Macleods Pharmaceuticals Recent Developments
  49. 8.9 HISUN
  50. 8.9.1 HISUN Company Information
  51. 8.9.2 HISUN Business Overview
  52. 8.9.3 HISUN Famciclovir Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 HISUN Famciclovir Product Portfolio
  54. 8.9.5 HISUN Recent Developments
  55. 8.10 Hikma
  56. 8.10.1 Hikma Company Information
  57. 8.10.2 Hikma Business Overview
  58. 8.10.3 Hikma Famciclovir Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Famciclovir Product Portfolio
  60. 8.10.5 Hikma Recent Developments
  61. 8.11 HETERO
  62. 8.11.1 HETERO Company Information
  63. 8.11.2 HETERO Business Overview
  64. 8.11.3 HETERO Famciclovir Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 HETERO Famciclovir Product Portfolio
  66. 8.11.5 HETERO Recent Developments
  67. 8.12 Cipla
  68. 8.12.1 Cipla Company Information
  69. 8.12.2 Cipla Business Overview
  70. 8.12.3 Cipla Famciclovir Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Cipla Famciclovir Product Portfolio
  72. 8.12.5 Cipla Recent Developments
  73. 8.13 Aurobindo Pharma
  74. 8.13.1 Aurobindo Pharma Company Information
  75. 8.13.2 Aurobindo Pharma Business Overview
  76. 8.13.3 Aurobindo Pharma Famciclovir Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Aurobindo Pharma Famciclovir Product Portfolio
  78. 8.13.5 Aurobindo Pharma Recent Developments
  79. 8.14 Apotex
  80. 8.14.1 Apotex Company Information
  81. 8.14.2 Apotex Business Overview
  82. 8.14.3 Apotex Famciclovir Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Apotex Famciclovir Product Portfolio
  84. 8.14.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Famciclovir Value Chain Analysis
  2. 9.1.1 Famciclovir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Famciclovir Sales Mode & Process
  6. 9.2 Famciclovir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Famciclovir Distributors
  9. 9.2.3 Famciclovir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst